Company intelligence / Profile preview
NanoSanguis
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
Overview
NanoSanguis is a Polish biotechnology company specializing in the development of synthetic oxygen carriers and advanced organ preservation systems. As a subsidiary of NanoGroup S.A., the company utilizes proprietary nanotechnology to develop 'artificial blood' (NanoRed) that mimics the oxygen-carrying capacity of red blood cells while offering a longer shelf life and universal compatibility. Their portfolio also includes NanoPreserve, a solution designed to extend the viability of organs during transport for transplantation. NanoSanguis focuses on addressing critical gaps in transfusion medicine and transplantology through innovative nanomedicine solutions. The company is a spin-off from the Warsaw University of Technology and maintains strong ties with academic research to drive its product development.
- Therapeutic areas
- HematologyCardiovascularImmunology
- Modalities
- NanoparticleSynthetic oxygen carrier
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on NanoSanguis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanoSanguis.